At the inaugural TTP Cambridge Cell & Gene Summit we have an exciting line up already confirmed, featuring participants from Achilles Therapeutics, Aglaris, AstraZeneca, GammaDelta Therapeutics, Mogrify and more. Attendees will learn first-hand how both large and small companies are pushing the boundaries of science and technology as they accelerate towards commercialisation of their cell and gene therapies and technologies. This is a great opportunity for attendees to reconnect with peers, connect with like-minded people and extend their networks. In addition, attendees will have the opportunity to participate in one of three workshops on the future of the cell and gene industry. The event concludes with a networking session over a light finger buffet and drinks.
Program
13:30 – Registration and networking with refreshments
14:00 – Welcome
14:10 – Keynote: Cell therapy developments: opportunities, challenges, and roadmap – Alessandra De Riva, Director of Process Development, Mogrify
14:40 – Keynote: Allogenic and tumour specific Vd1 CARs: Synergy between cell biology and gene engineering – Mihil Patel, Senior Scientist, Gene engineering and Immunology, GammaDelta Therapeutics
15:00 – Refreshment break
15:15 – Therapeutics workshop
15:15 – Cell therapy automation and tools workshop
15:15 – Cell therapy data analytics workshop
16:15 – Refreshment break
16:30 – Workshop wrap-up
17:00 – Panel Discussion: What’s next for cell therapy in the Innovation Corridor? Chaired by Kath Mackay, Managing Director, Bruntwood SciTech
Panellists:
– Damian Marshall, VP of Bioprocessing, Achilles Therapeutics
– David Horna, Director and COO, Aglaris
– Kevin Woollard, Director, Bioscience Renal, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca
– Kasia Averall, Head of Cluster Development, Cell and Gene Therapy Catapult
17:45 – Closing remarks
18:00 – Networking, light finger buffet and drinks
19:00 – Event end
About TTP
TTP is an independent technology company where scientists, engineers and designers collaborate to invent and develop new products and technologies. Working across a wide spectrum of industries, we create breakthrough solutions that bring strong commercial value to clients and the benefits of technology to all.
